Le Bonheur Children's Hospital trial: Intravenous indomethacin more effective for hsPDAs

July 22, 2020

Intravenous indomethacin is more effective than intravenous acetaminophen in treating hemodynamically significant PDAs (hsPDAs) in very low birth weight (VLBW) infants, according to new Le Bonheur Children's Hospital neonatology research published in the Journal of Perinatology.

Le Bonheur and the University of Tennessee Health Science Center neonatologists, led by Jennifer M. Davidson, DO, conducted a randomized trial for the treatment of hemodynamically significant PDAs (hsPDAs) in very low birth weight (VLBW) infants. Echocardiogram criteria before and after treatment showed that IV indomethacin was more effective.

"We have several options for PDA closure in these very low birth weight infants with varying levels of effectiveness including intervention by medication therapies," said Davidson.

Commonly used medical therapies are indomethacin and ibuprofen, but these have variable success and notable side effects. Surgical PDA ligation and transcatheter PDA closure can be used if medical therapies fail to close the PDA, but each comes with risks and lack of access for some hospitals. Studies have shown that, for some neonates, acetaminophen may be equally effecting for treating hsPDAs with minimal side effects. Le Bonheur neonatologists wanted to examine this option of IV acetaminophen for treating hsPDA in VLBW infants.

To be included in the trial, infants met specific criteria including gestational age at birth between 22 and 32 weeks, birth weight less than 1500 grams, 21 days of age or less and no previous pharmacologic treatment for PDA. Infants also had to meet strict echocardiogram criteria including left to right ductal flow and two out of three of the following: ductal size greater than or equal to 1.5 mm at smallest diameter, reversal of flow in descending aorta or left atrial size to aortic root ratio greater than or equal to 1.5.

Seventeen infants received 15 mg/kg dose of IV acetaminophen every six hours for 12 doses. Twenty infants received 3 doses of IV indomethacin every 12 hours with the amount of medication based on age. Each infant had a follow-up echocardiogram within seven days of the initiation of treatment. Successful PDA treatment was defined as no longer meeting the echocardiogram inclusion criteria for hsPDA.

Results of the study showed that IV indomethacin was more effective in successful treatment of hsPDA. The rate of successful PDA closure was 55 percent when using IV indomethacin and 6 percent when using IV acetaminophen.

"Through our study of very low birth weight infants, we were unable to show successful treatment of hsPDA with IV acetaminophen when compared to IV indomethacin in preterm infants born prior to 32 weeks," said Davidson. "In addition, many of our babies in the study treated with acetaminophen required interventional closure later on."

If acetaminophen continues to be used as a primary treatment of hsPDA, future studies should include a different dosing strategy or route of administration to learn more about its efficacy in PDA closure.
-end-
About Le Bonheur Children's:

Le Bonheur Children's Hospital in Memphis, Tenn., treats children through community programs, regional clinics and a 255-bed state-of-the-art hospital. Le Bonheur serves as a primary teaching affiliate for the University Tennessee Health Science Center and trains more than 350 pediatricians and specialists each year. Nationally recognized, Le Bonheur is ranked by U.S. News & World Report as a Best Children's Hospital.

For more information, please call (901) 287-6030 or visit lebonheur.org. Connect with us at facebook.com/lebonheurchildrens, twitter.com/lebonheurchild or on Instagram at lebonheurchildrens.

About University of Tennessee Health Science Center:

As Tennessee's only public, statewide, academic health system, the mission of the University of Tennessee Health Science Center is to bring the benefits of the health sciences to the achievement and maintenance of human health through education, research, clinical care, and public service, with a focus on the citizens of Tennessee and the region. The main campus in Memphis includes six colleges: Dentistry, Graduate Health Sciences, Health Professions, Medicine, Nursing and Pharmacy. UTHSC also educates and trains medicine, pharmacy, and/or health professions students, as well as medical residents and fellows, at major sites in Knoxville, Chattanooga and Nashville. For more information, visit http://www.uthsc.edu. Find us on Facebook: facebook.com/uthsc, on Twitter: twitter.com/uthsc and on Instagram: instagram.com/uthsc.

Le Bonheur Children's Hospital

Related Acetaminophen Articles from Brightsurf:

A pain reliever that alters perceptions of risk
While acetaminophen is helping you deal with your headache, it may also be making you more willing to take risks, a new study suggests.

Research shows ibuprofen does not hinder bone fracture healing in children
Doctors have traditionally avoided prescribing nonsteroidal anti-inflammatory medications (NSAIDs) such as ibuprofen to patients with fractures.

Le Bonheur Children's Hospital trial: Intravenous indomethacin more effective for hsPDAs
Le Bonheur and the University of Tennessee Health Science Center neonatologists, led by Jennifer M.

A prescription for the pain of rejection: Acetaminophen and forgiveness
A study, published recently in the Annals of Behavioral Medicine may have found an antidote to heartbreak -- forgiveness combined with acetaminophen, the active ingredient in Tylenol.

UTHealth's Cynthia Ju awarded NIH grants for liver injury research
Tiny solutions are being sought for big liver problems by a scientist at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).

Study examines fetal exposure to acetaminophen, risk of childhood ADHD, ASD
Umbilical cord blood samples were used to examine an association between fetal exposure to acetaminophen and risk of childhood attention-deficit/hyperactivity disorder, autism spectrum disorder and other developmental disabilities in a group of nearly 1,000 mother-child pairs.

NIH-funded study suggests acetaminophen in pregnancy linked to higher risk of ADHD, autism
Exposure to acetaminophen in the womb may increase a child's risk for attention deficit/hyperactivity disorder and autism spectrum disorder, suggests a study funded by the National Institutes of Health and the Agency for Health Care Research and Quality.

OHIO study: Acetaminophen can reduce positive empathy for others
A new study by an Ohio University faculty member showed that acetaminophen limited positive empathy a person has for others while taking it.

Scientists find new therapy target for drug-induced liver failure
Acetaminophen -- a commonly used pain reliever and fever reducer -- is the leading cause of quickly developing, or acute, liver failure in the U.S.

Acetaminophen may increase stroke risk for those with diabetes
Surprisingly, we are only now coming to understand how acetaminophen works -- and recent research shows that we may need to develop a better understanding of the need for caution when using acetaminophen, especially when it comes to avoiding some of the risks associated with its use.

Read More: Acetaminophen News and Acetaminophen Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.